Funding

Funding

RECENT FUNDING

The Boris Family Foundation Research Grant (2017 – 2020)
M. E. Bowdish, D. J. Davidson, M. Loeb, M. Surette – Value  CAN$ 330,000
“Mining the microbiota for novel immunomodulators”

OPTIMA (MRC / EPSRC) PhD studentship (2017 – 2020)
K. Faulds, D. J. Davidson, D. Graham – Value £ 97,042
“The assessment of host-defence peptide functionalised nanoparticles as microbicidal and immunomodulatory agents using Raman imaging”

MRC Project Grant (2014 – 2017)
J. Schwarze, R. Maizels, D. J. Davidson Value – £ 626,342
“Mechanisms of helminth induced antiviral immunity to RSV infection”

MRC Senior Non-clinical Fellowship (2011- 2017)
D. J. Davidson Value – £ 2,368,204
“Cathelicidins as immunomodulators of host defence against infectious diseases”

MRC Public Engagement Seed Funding (2016- 2017)
D. J. Davidson Value – £ 6,315
“Supercytes: Inflammation and Immunology Schools Resource”

Telethon-New Children’s Hospital Research Fund (2014 – 2016)
T. Strunk, A. J. Currie, D. J. Davidson, O. Levy, D. Burgner, K. Simmer
“Antimicrobial proteins and peptides to prevent late-onset sepsis in preterm infants”
Value – AUS$248,730.51

Wellcome Trust Institutional Strategic Support Fund 2 (2015)
D. J. Davidson
“Interactive Multimedia Public engagement projects for INFLAMMATION Research”
Value – £9,775

Walter Murdoch Distinguished Collaborator award (2011 – 2015)
D. J. Davidson, A. J. Currie
Value – AUS$30,000

Edinburgh Dermatology Research Fund (2014)
B. McHugh & D. J. Davidson Value – £3,914
“Novel antiproteases in atopic dermatitis”

Chief Scientist Office Clinical Training fellowship (2013)
P. Mandal, A. Rossi, D. J. Davidson & A. Hill Value – £ 214,029
“Deficiency in Lipoxin (LXA4) contributes to persistent neutrophilic airways inflammation in non cystic fibrosis bronchiectasis”

Wellcome Trust Career Development Fellowship (2006 – 2010)
D. J. Davidson Value – £ 581,392
“The role of the human cathelicidin LL-37 as an immunomodulator in infectious lung disease”